Visionflex Group Ltd (VFX) fair value: what the stock is really worth
As of Oct 5, 2026: fair value of Visionflex Group Ltd A$0.03, price A$0.04, upside -14.1%, quality 42 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Oct 4, 2026.
How to read this chart
60‑month range A$0.0340 – A$4.34 · fair‑value band A$0.0287 – A$0.0318 · the A$0.0370 price screens above the A$0.0318 fair value. Dashed = 300-day average. As of Oct 4, 2026.
Follow Visionflex Group in your weekly email
Every Wednesday you see whether Visionflex Group is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. The company offers virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care.
Show more
Visionflex Group Limited, together its subsidiaries, engages in the provision of healthcare, telehealth, and remote diagnostic solutions in Australia. The company offers virtual healthcare solutions and peripheral medical devices that integrate into proprietary developed software for remote diagnostics and patient care. It also provides healthcare and corporate online search and appointment booking services. The company was formerly known as 1st Group Limited and changed its name to Visionflex Group Limited in November 2023. Visionflex Group Limited was incorporated in 2009 and is based in Warriewood, Australia.
Stock analysis
Visionflex Group Ltd (VFX) currently trades at A$0.0370, while our model-based Fair Value estimate is A$0.0318, 14.1% below the price, so the stock looks overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 96/100, which puts the evidence level at low.
Scenario range: A$0.0287 (bear) to A$0.0318 (bull), the price of A$0.0370 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 42/100 (below-average quality), in the Healthcare sector.
Weak Growth: Revenue is shrinking: the last year, the last three and the last five years are all negative.
Visionflex Group Ltd reported revenue of A$4.1M in FY2026 versus A$4.8M in FY2022, a compound −3.8%/yr. Reported net income was −A$57.8K in FY2026.
Key figures
Market cap A$3.2M (≈ $2.2M) · P/S ratio 0.75 · Net margin −1.4% · Return on assets (EBIT) −82.5% · Operating margin 45.5% · Revenue (TTM) A$4.2M · Revenue growth (YoY) +49.0% · Free cash flow −A$1.3M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 75% below its 52-week high and 9% above its 52-week low, currently below its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −14%, VFX screens richer than that median.
Fair Value models
Bear A$0.0287Fair Value A$0.0318Bull A$0.0318
Price A$0.0370 · Upside -14.1%
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.0/100
Revenue is shrinking: the last year, the last three and the last five years are all negative.
Revenue growth 1 year
−1.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−2.5%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
−5.1%
Start year 2021 (pandemic)
’21
’22
’23
’24
’25
’26
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−61.2% (2021) → −51.0% (2026)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2026 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Health Information Services · 117 stocks
Beats the industry median on 4/7 measures
A mixed picture versus its industry peers.
Valuation
Quality Score42 · Bottom 25%
Fair Value upside−11.7% · Above median
Profitability
Return on equity (TTM)Negative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Return on assets−8.5% · Bottom 25%
Net margin (TTM)−1.4% · Below median
Operating margin (TTM)45.5% · Top 25%
Growth and dividend
Revenue growth49.0% · Top 25%
Balance sheet
Debt / equityNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
Valuation Multiplesvs Health Information Services median · lower = cheaper
P/BNegative equity ⓘThe company's equity is below zero, for example after large share buybacks. A ratio to negative equity has no meaning, so we show no number here and do not rank it against the peer group.
P/S (TTM)0.52× · Cheapest 25%
Strength profile in five axes (Snowflake)
This stockSector peers
VALUE (fair-value potential)18· sector 0
FUTURE (revenue growth)100· sector 42
PAST (return on equity)0· sector 12
HEALTH (low debt)0· sector 98
DIVIDEND (yield)0· sector 44
PAST 0: with negative equity (buybacks among others) return on equity is not meaningfully computable.
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Cite: Fair Value Calculator (2026). "Visionflex Group Ltd Fair Value". https://www.fairvalue-calculator.com/stock/VFX
Frequently asked questions
Is Visionflex Group Ltd (VFX) overvalued or undervalued?
As of Oct 4, 2026, our model estimates a fair value of A$0.0318 versus a price of A$0.0370, about −14% upside (overvalued).
What is the fair value of VFX?
Our model-based fair value for Visionflex Group Ltd is A$0.0318 (as of Oct 4, 2026), built from audited fundamentals. The current price: A$0.0370.
What is the quality score of VFX?
Visionflex Group Ltd has a Quality Score of 42/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Visionflex Group Ltd (VFX)?
Our model-based price target is the fair value of A$0.0318 (as of Oct 4, 2026) from 1 valuation models. Cautious scenario A$0.0287, optimistic scenario A$0.0318. It is a calculation from audited fundamentals, not an analyst target.
What is the Visionflex Group Ltd stock forecast for 2026?
Our models put fair value at A$0.0318, about −14% upside versus a price of A$0.0370 (overvalued). Cautious scenario A$0.0287, optimistic scenario A$0.0318. The calculation is refreshed regularly with new filings.
What is the revenue of Visionflex Group Ltd (VFX)?
Visionflex Group Ltd reported trailing-twelve-month revenue of about A$4.2M (latest available figure, as of Oct 4, 2026).
What is the intrinsic value of Visionflex Group Ltd (VFX)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Visionflex Group Ltd it is A$0.0318 per share (as of Oct 4, 2026), against a price of A$0.0370. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Visionflex Group Ltd stock overvalued or undervalued in 2026?
As of Oct 4, 2026, VFX trades above its calculated fair value: price A$0.0370, fair value A$0.0318, a gap of about −14% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of VFX?
No. The price is what the market pays today (A$0.0370); the fair value is what the company's own numbers justify (A$0.0318). For Visionflex Group Ltd the two are A$0.0052 per share apart. That gap is exactly why we show both numbers side by side.
How much is Visionflex Group Ltd worth?
The market values Visionflex Group Ltd at about A$3.2M (market capitalisation, as of Oct 4, 2026). Per share that is A$0.0370; our models calculate a fair value of A$0.0318 per share.
What do the bullish and bearish scenarios say about VFX?
Our models span a range for Visionflex Group Ltd: cautious scenario A$0.0287, base A$0.0318, optimistic A$0.0318 per share (as of Oct 4, 2026, price A$0.0370). The range comes from different growth and margin assumptions, not from analyst opinions.
How solid is the balance sheet of Visionflex Group Ltd (VFX)?
Balance-sheet figures for Visionflex Group Ltd (as of Oct 4, 2026): negative equity, so no return on equity and no debt-to-equity ratio. They feed the Quality Score of 42/100, which measures business quality independently of the share price.
How far is VFX from its 52-week high?
Visionflex Group Ltd trades at A$0.0370, about 75% below its 52-week high of A$0.1500 and 9% above the low of A$0.0340 (as of Oct 5, 2026). Distance from the high says nothing about value: that is what the fair value of A$0.0318 is for.
Which stocks are comparable to Visionflex Group Ltd?
From the same area (Healthcare) we also value Veeva Systems Inc, Pro Medicus Limited, BrightSpring Health Services, Inc, Hinge Health, Inc, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Visionflex Group Ltd stock attractive at the current price?
The data as of Oct 4, 2026: price A$0.0370, calculated fair value A$0.0318 (−14%), Quality Score 42/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of VFX calculated?
We run Visionflex Group Ltd through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of A$0.0318, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 15.0 % above its aggregate fair value. Visionflex Group Ltd itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Visionflex Group Ltd (VFX)?
The closing price on Oct 5, 2026 was A$0.0370. Our model-based fair value is A$0.0318, about −14% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Visionflex Group Ltd right now?
The price sits above even our optimistic bull case (A$0.0318). The favourable scenario is already priced in. The models converge in a tight band (A$0.0287 to A$0.0318), unusually little disagreement for a valuation. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Visionflex Group Ltd
How large is the market capitalisation of Visionflex Group Ltd (VFX)?
The market capitalisation of Visionflex Group Ltd is A$3.2M (≈ $2.2M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Visionflex Group Ltd (VFX)?
The price-to-sales ratio of Visionflex Group Ltd is 0.75 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the net margin of Visionflex Group Ltd (VFX)?
The net margin of Visionflex Group Ltd is −1.4% (fiscal year 2026). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the EBIT return on assets of Visionflex Group Ltd (VFX)?
On an EBIT basis the return on assets of Visionflex Group Ltd is −82.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Visionflex Group Ltd (VFX)?
The operating margin of Visionflex Group Ltd is 45.5% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Visionflex Group Ltd (VFX)?
Revenue at Visionflex Group Ltd is growing +49.0% versus a year earlier (3y avg −2.5%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Visionflex Group Ltd (VFX) generate?
The free cash flow of Visionflex Group Ltd is −A$1.3M (fiscal year 2026). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Visionflex Group Ltd (VFX) hold?
Visionflex Group Ltd holds more cash than debt, A$1.0M net (fiscal year 2026). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Visionflex Group Ltd in the live analysis
One click puts Visionflex Group Ltd on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
